Tri-Mix Injection

What is Trimix?

Trimix is an injectable medication comprised of papaverine, phentolamine, and alprostadil used as a treatment for erectile dysfunction (ED). Trimix injections can trigger an erection within 5 minutes and result in longer and firmer erections that last through climax. Since Trimix dosages are customized to each patient’s needs, the drug must be used according to our prescribed treatment plan..

Erectile dysfunction (ED), a sexual health condition characterized by the inability to achieve or maintain an erection, affects an estimated 30-60 million men in the Nigeria with Hundreds of thousands of new cases arising each year. While ED can occur in younger men, it becomes more prevalent after age 40.

Trimix is an injectable medicine used to treat erectile dysfunction (ED). It contains papaverine, phentolamine, and alprostadil. Trimix injections can cause an erection in 5 minutes and provide longer, harder erections that continue till climax. Because Trimix doses are tailored to each patient’s specific needs, the medication must be administered in accordance with our treatment plan.

Erectile dysfunction (ED), a sexual health issue defined by the inability to develop or sustain an erection, affects an estimated 30-60 million men in Nigeria, with hundreds of thousands of new cases diagnosed each year. While ED can occur in younger men, it becomes more common around 40.

Trimix aims to provide a reliable, easy, safe way for men with ED to achieve and sustain erections firm enough for sex. Its main benefits include:

Trimix intends to provide a dependable, simple, and safe method for men with ED to obtain and maintain erections strong enough for intercourse. Its major advantages include:

• • Efficacy
• • Simple storage
• • Long duration
• • Easy self-administration

Trimix was developed in 1983 when scientists discovered that adding phentolamine and alprostadil to papaverine, at the time a standalone ED treatment, created a more effective compound. Today, Trimix injections are an accepted second-line ED medication when oral PDE5 inhibitors, like Viagra, Levitra, or Cialis, are ineffective or create side effects.  Since Trimix works locally where it is injected, rather than circulating throughout the bloodstream like oral drugs, it tends to have a lower risk of side effects.

Trimix was developed in 1983 after scientists discovered that combining phentolamine and alprostadil to papaverine, which was previously used as a single ED therapy, resulted in a more effective combination. Trimix injections are now a common second-line ED treatment when oral PDE5 inhibitors such as Viagra, Levitra, or Cialis are unsuccessful or cause negative effects.  Trimix operates locally where it is injected, rather than traveling throughout the circulation like oral medications, therefore it has a lesser chance of adverse effects.